# Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease

> **NCT05971329** · NA · RECRUITING · sponsor: **Zetagen Therapeutics, Inc** · enrollment: 10 (estimated)

## Conditions studied

- Radiculopathy, Cervical
- Myelopathy Cervical
- Neurological Abnormality
- Disc Disease
- Disc Degeneration

## Interventions

- **DEVICE:** Cervical Fusion (ZetaFuse™ Bone Graft)

## Key facts

- **NCT ID:** NCT05971329
- **Lead sponsor:** Zetagen Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2026-09
- **Final completion:** 2027-09
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05971329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05971329, "Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05971329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*